Cover Image
市場調查報告書

住宅塵蟎過敏:全球臨床實驗檢討

House Dust Mite Allergy Global Clinical Trials Review, H2, 2017

出版商 GlobalData 商品編碼 318337
出版日期 內容資訊 英文 81 Pages
訂單完成後即時交付
價格
Back to Top
住宅塵蟎過敏:全球臨床實驗檢討 House Dust Mite Allergy Global Clinical Trials Review, H2, 2017
出版日期: 2017年09月22日 內容資訊: 英文 81 Pages
簡介

住宅塵蟎過敏,塵蟎產生的引發過敏物質造成的過敏反應。

本報告提供住宅塵蟎過敏的治療藥相關臨床實驗調查分析,提供您臨床實驗數及受驗人數,各階段、及Phase狀況,有潛力的企業,正在開發的治療藥資訊,臨床實驗簡介等相關的系統性資訊。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中南美的主要國家

G7各國的臨床實驗:免疫系臨床實驗上住宅塵蟎過敏所佔的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:各階段

E7各國的臨床實驗:免疫系臨床實驗上住宅塵蟎過敏所佔的比例

E7各國的臨床實驗:Phase別

E7各國的臨床實驗:各階段

各方面的臨床實驗

各階段臨床實驗

評估項目別臨床實驗

未完成的臨床實驗

一定期間所採用的實驗對像

贊助商類別臨床實驗

有潛力的贊助商

  • 住宅塵蟎過敏的治療藥臨床實驗的主要參與企業

有前途藥物

臨床實驗簡介

  • 主要企業臨床實驗概要
    • ALK-Abello A/S
    • Stallergenes S.A.
    • Merck & Co., Inc.
    • Circassia Holdings Ltd.
    • Laboratorios LETI S.L.
    • 日本煙草產業
    • Cytos Biotechnology AG (暫停中)
    • Merck KGaA
    • Lofarma S.p.A.
    • Anergis SA
  • 主要大學·研究機關·醫院臨床實驗概要
    • Medical University of Lodz
    • Johann Wolfgang Goethe University Hospitals
    • Universitaire Ziekenhuizen Leuven
    • Academic Medical Center
    • Ankara University
    • Aalborg University
    • University of South Florida
    • Medical University of Silesia
    • Bayside Health
    • Medical University of Vienna

主要的臨床簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4598CTIDB

GlobalData's clinical trial report, "House Dust Mite Allergy Global Clinical Trials Review, H2, 2017" provides an overview of House Dust Mite Allergy clinical trials scenario. This report provides top line data relating to the clinical trials on House Dust Mite Allergy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 5
  • Report Guidance 6
  • GlobalData Clinical Trials Report Coverage 7
  • Clinical Trials by Region 8
  • Clinical Trials and Average Enrollment by Country 9
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 12
  • Top Five Countries Contributing to Clinical Trials in Europe 13
  • Top Countries Contributing to Clinical Trials in North America 14
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 15
  • Top Countries Contributing to Clinical Trials in Central and South America 16
  • Clinical Trials by G7 Countries: Proportion of House Dust Mite Allergy to Immunology Clinical Trials 17
  • Clinical Trials by Phase in G7 Countries 19
  • Clinical Trials in G7 Countries by Trial Status 20
  • Clinical Trials by E7 Countries: Proportion of House Dust Mite Allergy to Immunology Clinical Trials 21
  • Clinical Trials by Phase in E7 Countries 23
  • Clinical Trials in E7 Countries by Trial Status 24
  • Clinical Trials by Phase 25
  • In Progress Trials by Phase 26
  • Clinical Trials by Trial Status 27
  • Clinical Trials by End Point Status 28
  • Subjects Recruited Over a Period of Time 29
  • Clinical Trials by Sponsor Type 30
  • Prominent Sponsors 31
  • Top Companies Participating in House Dust Mite Allergy Therapeutics Clinical Trials 33
  • Prominent Drugs 35
  • Latest Clinical Trials News on House Dust Mite Allergy 37
  • Sep 14, 2017: Successful Phase III trial for ALKs tree allergy SLIT-tablet 37
  • Aug 21, 2017: ALK to accelerate launches of ODACTRA in the USA / ACARIZAX in Canada 37
  • Jul 27, 2017: Stallergenes Greer Announces Completion of Enrollment in Largest Phase III Study to Treat House Dust Mites Allergy 37
  • Clinical Trial Profile Snapshots 39

Appendix 85

  • Abbreviations 85
  • Definitions 85
  • Research Methodology 86
  • Secondary Research 86
  • About GlobalData 87
  • Contact Us 87
  • Source 88

List of Tables

List of Tables

  • House Dust Mite Allergy Therapeutics, Global, Clinical Trials by Region, 2017* 8
  • House Dust Mite Allergy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • House Dust Mite Allergy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
  • House Dust Mite Allergy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 12
  • House Dust Mite Allergy Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 13
  • House Dust Mite Allergy Therapeutics Clinical Trials, North America, Top Countries, 2017* 14
  • House Dust Mite Allergy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 15
  • House Dust Mite Allergy Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 16
  • Proportion of House Dust Mite Allergy to Immunology Clinical Trials, G7 Countries (%), 2017* 17
  • House Dust Mite Allergy Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 19
  • House Dust Mite Allergy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 20
  • Proportion of House Dust Mite Allergy to Immunology Clinical Trials, E7 Countries (%), 2017* 21
  • House Dust Mite Allergy Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 23
  • House Dust Mite Allergy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 24
  • House Dust Mite Allergy Therapeutics, Global, Clinical Trials by Phase, 2017* 25
  • House Dust Mite Allergy Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 26
  • House Dust Mite Allergy Therapeutics, Global, Clinical Trials by Trial Status, 2017* 27
  • House Dust Mite Allergy Therapeutics Clinical Trials, Global, by End Point Status, 2017* 28
  • House Dust Mite Allergy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 29
  • House Dust Mite Allergy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 30
  • House Dust Mite Allergy Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 31
  • House Dust Mite Allergy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 33
  • House Dust Mite Allergy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 35

List of Figures

List of Figures

  • House Dust Mite Allergy Therapeutics, Global, Clinical Trials by Region (%), 2017* 8
  • House Dust Mite Allergy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • House Dust Mite Allergy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
  • House Dust Mite Allergy Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 12
  • House Dust Mite Allergy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 13
  • House Dust Mite Allergy Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 14
  • Proportion of House Dust Mite Allergy to Immunology Clinical Trials, G7 Countries (%), 2017* 17
  • House Dust Mite Allergy Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 19
  • House Dust Mite Allergy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 20
  • Proportion of House Dust Mite Allergy to Immunology Clinical Trials, E7 Countries (%), 2017* 21
  • House Dust Mite Allergy Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 23
  • House Dust Mite Allergy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 24
  • House Dust Mite Allergy Therapeutics, Global, Clinical Trials by Phase (%), 2017* 25
  • House Dust Mite Allergy Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 26
  • House Dust Mite Allergy Therapeutics, Global, Clinical Trials by Trial Status, 2017* 27
  • House Dust Mite Allergy Therapeutics Clinical Trials, Global, by End Point Status, 2017* 28
  • House Dust Mite Allergy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 29
  • House Dust Mite Allergy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 30
  • House Dust Mite Allergy Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 31
  • House Dust Mite Allergy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 33
  • House Dust Mite Allergy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 35
  • GlobalData Methodology 86
Back to Top